NEU 0.15% $13.13 neuren pharmaceuticals limited

It is safe assumption that the numbers from the Ascend...

  1. 1,827 Posts.
    lightbulb Created with Sketch. 274
    It is safe assumption that the numbers from the Ascend presentation were taken from the Q1 numbers that were published. The updated corporate presentation uses the exact same figures from May.

    My comment regarding guidance being on track is only assumption because if Acadia knew in July that there was no chance that guidance was going to be hit, they wouldn't release a corporate presentation to fuel speculation that they withheld information from the market, rather than release it. If things are going to plan (or within a range) there's no obligation. Ie - no news is good news, sometimes!

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.